Health Catalyst Inc. (HCAT)
NASDAQ: HCAT
· Real-Time Price · USD
2.86
0.01 (0.35%)
At close: Sep 24, 2025, 3:59 PM
2.89
1.05%
After-hours: Sep 24, 2025, 04:38 PM EDT
Health Catalyst Revenue Breakdown
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Recurring Technology Revenue | 52.88M | 51.48M | 99.23M | 48.65M | 47.63M | 46.97M | 47M | 45.97M | 47.32M | 46.93M | 44.66M | 44M | 45.4M | 41.75M | 40.09M | 38.26M | 35.53M | 33.57M | 32.32M | 27.96M | 25.49M | 24.7M | 22.4M | 21.16M | 20.09M |
| Recurring Technology Revenue Growth | +2.71% | -48.12% | +103.96% | +2.14% | +1.42% | -0.07% | +2.24% | -2.85% | +0.84% | +5.07% | +1.52% | -3.08% | +8.74% | +4.15% | +4.77% | +7.69% | +5.85% | +3.87% | +15.57% | +9.72% | +3.19% | +10.27% | +5.85% | +5.35% | n/a |
Operating Expense Breakdown
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 | Sep 30, 2018 | Jun 30, 2018 | Mar 31, 2018 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selling, General, and Administrative Revenue | 21.49M | 28.9M | 26.92M | 23.55M | 23.85M | 33.62M | 27.17M | 26.92M | 40.07M | 42.4M | 36.52M | 44.59M | 38.46M | 29.64M | 47.2M | 43.86M | 39.23M | 30.67M | 42.92M | 27.93M | 20.61M | 23.19M | 20.09M | 25.73M | 16.53M | 16.65M | 17.57M | 19.38M | 19.25M | 10.62M |
| Selling, General, and Administrative Revenue Growth | -25.64% | +7.34% | +14.32% | -1.26% | -29.06% | +23.75% | +0.93% | -32.82% | -5.50% | +16.10% | -18.10% | +15.95% | +29.75% | -37.20% | +7.61% | +11.81% | +27.93% | -28.55% | +53.70% | +35.46% | -11.10% | +15.45% | -21.95% | +55.67% | -0.70% | -5.25% | -9.33% | +0.68% | +81.16% | n/a |
| Research and Development Revenue | 12.39M | 15.19M | 15M | 14.19M | 13.88M | 14.87M | 20.29M | 17.67M | 17.59M | 17.08M | 19.61M | 20.77M | 18.15M | 17.15M | 17.48M | 16.39M | 14.52M | 14.35M | 14.98M | 13.39M | 12.06M | 13.09M | 13.04M | 13.48M | 9.71M | 10.02M | 10.56M | 10.84M | 8.49M | 8.71M |
| Research and Development Revenue Growth | -18.40% | +1.23% | +5.70% | +2.23% | -6.64% | -26.70% | +14.84% | +0.44% | +2.97% | -12.91% | -5.57% | +14.45% | +5.83% | -1.89% | +6.68% | +12.81% | +1.25% | -4.23% | +11.86% | +11.02% | -7.85% | +0.35% | -3.22% | +38.80% | -3.11% | -5.10% | -2.56% | +27.71% | -2.50% | n/a |
| Sales and Marketing Revenue | 13.21M | 14.74M | 11.24M | 11.34M | 12.22M | 19.06M | 15.67M | 14.98M | 16.4M | 18.57M | 20.37M | 25.4M | 20.92M | 20.82M | 21.86M | 20.81M | 16.7M | 15.65M | 14.79M | 14.63M | 12.5M | 13.49M | 11.71M | 14.72M | 10.38M | 10.47M | 11.63M | 13.77M | 12M | 6.72M |
| Sales and Marketing Revenue Growth | -10.39% | +31.10% | -0.88% | -7.20% | -35.87% | +21.64% | +4.58% | -8.63% | -11.70% | -8.85% | -19.79% | +21.41% | +0.50% | -4.78% | +5.07% | +24.56% | +6.73% | +5.80% | +1.12% | +17.01% | -7.30% | +15.22% | -20.49% | +41.75% | -0.84% | -9.93% | -15.57% | +14.72% | +78.60% | n/a |